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Abstract 
Molecular tools to stabilize -hairpin conformation are needed as -hairpin peptides are useful 
molecules for pharmaceutical, biological and material applications. We explored the use of a 
“triazole bridge”, a covalent link between two -hairpin strands obtained through Cu-catalyzed 
alkyne-azide cycloaddition, combined with an aromatic-aromatic interaction. High 
conformationally stable peptides were identified by NMR screening of a small collection of cyclic 
peptides based on the Trpzip2 scaffold. The characteristic Trp-Trp interaction of Trpzip2 was 
replaced by a diagonal triazole bridge of variable length. NMR and CD analyses showed that 
triazole and indole rings could favorable interact to stabilize a -hairpin conformation. The 
conformational stabilization depends on the length of the triazole bridge and the reciprocal position 
between the aromatic rings. Combining aromatic interactions and the covalent inter-strands triazole 
bridge is an useful strategy to obtain peptides with high -hairpin content. 
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Introduction 
β-hairpin peptides are useful molecules for pharmaceutical and biomedical applications1-3. They are 
also attractive to modulate protein-protein interactions
4-8
. Stability and formation of β-hairpin have 
been deeply analyzed
9-14
 and molecular tools have been developed to design conformationally 
stable β-hairpin peptides9,15-18. In the last years, we and others19 have analyzed the conformational 
stability of -hairpin peptides presenting a triazole bridge, with variable lengths, in a non-hydrogen 
bonded position (NHB)
20
 and in a hydrogen bonded position (HB)
21
. The “triazole bridge” is a 1-4 
disubstituted 1,2,3-triazole, obtained by side chain-side chain cyclization through Cu-catalyzed 
alkyne-azide cycloaddition (CuAAC),
22,23
 forming a covalent linkage between -hairpin strands. 
These previous studies have established that the formation of the inter-strands triazole bridge is an 
effective strategy to constrain peptides in a stable -hairpin conformation and the optimal bridge 
length depends on the specific -hairpin position (NHB or HB) of the tool19-21. However, we 
obtained peptides with a -hairpin content lower than the tryptophan zipper 2 (Trpzip2)17,24, a 12-
mer peptide characterized by a cluster of cross-strands interactions between four tryptophan 
residues, which we refer as folded -hairpin peptide.  
Aromatic-aromatic interactions are important in stabilizing the structure of proteins
25,26
, peptides
27-
31
 and in molecular recognition process
32,33
. In particular, aromatic interactions have been exploited 
to design stable -hairpin peptides6,17,34-36. The 1,2,3-triazole is an aromatic heterocycle, 
nevertheless its role in establishing aromatic-aromatic interactions has never been explored for 
conformation stabilization purposes. We envisioned that if the triazole ring interacts with Trp, it 
will be possible to combine two stabilizing effects for a -hairpin peptide: aromatic interactions and 
inter-strand covalent linkage. 
In this work, we aim to obtain a high conformationally stable -hairpin peptide combining 
aromatic-aromatic interactions and an inter-strand covalent linkage such as the triazole bridge. To 
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get this aim we designed a series of -hairpin peptides presenting the triazole bridge in a diagonal 
non-hydrogen bonded (DNHB) position close to tryptophan side chain. 
 
Results and discussion 
Peptide Design and Synthesis. A set of nine peptides (Fig.1 and Fig.S1) was designed based on the 
Trpzip2 peptide, which presents a well-characterized -hairpin structure and possesses an excellent 
thermodynamic stability
17
. Trpzip2 consists of a ENGK sequence, to promote a type I' turn, flanked 
by the tripeptide sequence WTW on both strands. The Trp residues are located in the NHB 
positions 2, 4, 9 and 11.  
In our previous studies on the role of triazole bridge in NHB positions in -hairpin peptides, we 
observed a weak NOE contact between Trp in position 2 and the cross-strand triazole bridge linking 
NHB positions 4 and 9, but we excluded any effect of triazole-tryptophan interaction on peptide 
stability
20
. In order to bring the two aromatic rings (triazole and indole) close and in a more 
favorable structural arrangement for interaction, we inserted the triazole bridge, with a diagonal 
arrangement, in the NHB positions 2 and 9 and leave the Trp in position 4 on the N-terminal strand. 
Previous works on diagonal non-covalent interactions showed that they can contribute to the 
stability of a -hairpin peptide37,38. In analogy with our previous works, starting with Trpzip2 
sequence, we replaced Trp11 with a Val residue and Trp2 and Trp9, respectively, with alkyne and 
azide amino acids having different side chain lengths to determine the optimal bridge length for the 
-hairpin conformational stabilization. The schematic and complete sequences are reported in figure 
1. 
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Figure 1: Schematic representation and amino acid sequence of DNHB peptides. Xaa are alkyne 
amino acids: propargilglycine (Pra), homopropargilglycine (Hpg), bishomopropargilglycine (Bpg); 
Yaa are azide amino acids: L--azidoalanina (Dap(N3)), L--azidohomoalanine (Dab(N3)), L--
azidoornitine (Orn(N3)). 
 
Peptides were synthesized by Fmoc solid phase peptide synthesis. The alkyne amino acids 
propargilglycine (Pra), homopropargilglycine (Hpg), bishomopropargilglycine (Bpg) and the azido 
amino acids L--azidoalanina (Dap(N3)), L--azidohomoalanine (Dab(N3)), L--azidoornitine 
(Orn(N3)) were incorporated in the peptide sequence in different combinations. The purified 
peptides were subjected to an intramolecular CuAAC leading to the formation of a triazole bridge 
of different lengths (from two to six units) according to the number of methylene groups of the 
Ser -Xaa-Thr-Trp-Glu-Asn-Gly-Lys-Yaa-Thr-Val-Lys-NH2
Peptide Sequencea x y
Trpzip2 S-W-T-W-E-N-G-K-W-T-W-K-NH2 - -
DNHB 1.1 S-Pra-T-W-E-N-G-K-Dap(N3)-T-V-K-NH2 1 1
DNHB 1.2 S-Pra-T-W-E-N-G-K-Dab(N3)-T-V-K-NH2 1 2
DNHB 1.3 S -Pra-T-W-E-N-G-K-Orn(N3)-T-V-K-NH2 1 3
DNHB 2.1 S-Hpg-T-W-E-N-G-K-Dap(N3)-T-V-K-NH2 2 1
DNHB 2.2 S-Hpg-T-W-E-N-G-K-Dab(N3)-T-V-K-NH2 2 2
DNHB 2.3 S-Hpg-T-W-E-N-G-K-Orn(N3)-T-V-K-NH2 2 3
DNHB 3.1 S-Bpg-T-W-E-N-G-K-Dap(N3)-T-V-K-NH2 3 1
DNHB 3.2 S-Bpg-T-W-E-N-G-K-Dab(N3)-T-V-K-NH2 3 2
DNHB 3.3 S-Bpg-T-W-E-N-G-K-Orn(N3)-T-V-K-NH2 3 3
DNHB 2.2rev S-Dab(N3)-T-W-E-N-G-K-Hpg-T-V-K-NH2 2 2
DNHB 2.2W3 S-Hpg-W-T-E-N-G-K-Dab(N3)-T-V-K-NH2 2 2
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alkyne and azido substituents (Fig. 1). As a proof of intramolecular cyclization by CuAAC and the 
occurred formation of 1,4 -disubstituted 1,2,3-triazole bridge we verified that: a) the linear peptides 
and the corresponding cyclized peptides have the same molecular mass but different HPLC elution 
times as already reported
20,39
 (see Experimental section and figure S2 and S3); b) the absence of odd 
multi-charged peaks in the ESI-MS spectra suggesting the monomeric nature of the peptides (ESI-
MS spectra of linear and cyclized peptides are reported in Figure S2 and S3); c) the cyclized 
peptides are stable to treatment with TCEP (as result of triazole formation), while linear peptides, in 
the same conditions, loss 26 Da as a consequence of the reduction of azide group to amine
20,40
 (see 
Experimental section ). 
 
Circular dichroism analysis. In order to study the conformational properties of the synthesized 
peptides, circular dichroism (CD) spectroscopy analyses were performed in phosphate buffer at pH 
6.6. CD spectra of linear DNHB peptides (Fig. S4) show an intense negative band at around 200 nm 
with a weak negative shoulder in the range 215-220 nm, suggesting that the linear peptides assume 
a predominantly unordered conformation in aqueous solution
41
.  
In contrast, cyclic DNHB peptides spectra show a negative band between 196 and 198 nm, less 
intense and blue-shifted of few nanometers with respect to the linear peptide, a negative band of 
variable intensity around 215 nm and a positive band at 227-229 nm is also present for few peptides 
(Fig. S5). 
CD spectrum of a -structure in the far-UV-region is characterized by a negative band around 217 
nm and a positive band under 200 nm arising respectively from n-* and -* transitions of the 
backbone amide groups. These bands could be masked, in peptide presenting aromatic residues, by 
-* transitions arising from interacting aromatic rings. This is the case of Trpzip peptides, whose 
CD spectra are dominated by exciton coupling between indole rings which produces a characteristic 
band splitting with a positive maximum at 225 and negative minimum at 218 nm
17,24
. -hairpin 
peptides presenting interactions involving a Trp and an aromatic residue other than Trp have been 
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reported, for example Trp-Tyr, Trp-Phe
42-44
. Their CD spectra are characterized by multiple bands 
making unambiguous interpretation difficult. In general, a less intense positive band at 225 nm is 
observed, the negative band at 218 nm become a shoulder of a more intense negative band around 
200 nm.  
CD spectra analysis of cyclic DNHB peptides is not trivial as several factors can contribute to the 
spectra observed; in fact, the DNHB peptides differ for -structure content, -turn folding, strands 
twist imposed by the triazole bridge and strength of aromatic-aromatic interaction. However, we 
suppose that the anomalous far-UV spectra of cyclic DNHB peptides mainly reflect the interaction 
between the triazole and indole rings and the spectra diversity depends on the different geometry of 
interaction, which is dictated by the constrain imposed by the covalent cyclization through the 
triazole bridge. This hypothesis is supported by the CD spectra of DNHB2.2W3 peptide (Fig. S6). 
This peptide (sequence in figure 1) presents non-interacting aromatic rings as the triazole and the 
Trp side chain are on opposite sides of the -hairpin. Its CD spectrum has a shape very similar to 
that of linear peptide with a minimum at 201 nm, a shoulder around 220 nm but no evident bands in 
the 215-220 nm region. DNHB2.2W3 peptide shows a low -hairpin content, as determined by 
NMR (see next paragraph), but cyclic DNHB peptides with a similar -hairpin content, for example 
DNHB1.1 or DNHB1.2, show a completely different CD spectrum (Fig. S5, left panel). These 
observations suggest that the CD spectrum of cyclic DNHB2.2W3 is indicative of a peptide with 
low -hairpin content in absence of aromatic interactions (NMR analysis excluded any NOE 
contact between the two rings, see infra).  
 
Evaluation of -hairpin content by NMR spectroscopy. A combination of 1H one-dimensional (1D) 
and bi-dimensional (2D) DQF-COSY, TOCSY, NOESY data sets were used to determine if DNHB 
peptides, both linear and cyclic, were folded into β-hairpin structures and to what extent they were 
folded. 
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The 1D 
1
H NMR spectra of linear peptides showed amide chemical shift dispersions typical of 
unordered structures; after cyclization the peptides acquired a good chemical shift dispersion of the 
backbone amide protons, as occurs in a folded peptide (Fig. 2 and Fig. S7). Furthermore, the hairpin 
conformation for all cyclic peptides was confirmed by the splitting of the diastereotopic H atoms 
of the turn Gly7 residue (ΔδGly), as showed in Figure 2B. 
 
 
Figure 2: A) 
1
H spectra of linear (lower) and cyclic (upper) DNHB 2.2 peptide in water solution. B) 
Section of the 2D [
1
H, 
1
H] TOCSY spectra of linear (left) and cyclic (right) DNHB 2.2 peptide. The 
arrows in the 2D [
1
H, 
1
H] TOCSY spectra highlight the Gly7 H protons. Spectra were recorded in 
water solution at 400 MHz and at 298 K. 
 
The conformational properties of the cyclic peptides were qualitatively analyzed by comparing Hα 
chemical shifts relative to random coil values (ΔδHα)45. In particular, as shown in Figure 3, residues 
2-4 and 9-11 show significant downfield shifts consistent with the pattern expected for an 
antiparallel β-sheet. Asn6, Gly7, Lys8 are upfield shifted as typically detected for residues in turn 
conformation while Ser1 and Lys12 are in a random coil conformation as usually observed at N- 
and C- termini. 
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Figure 3: Hα chemical shift difference (ΔδHα) for Trpzip2 and for cyclic DNHB peptides. 
 
Therefore, the extent of β-hairpin folding of each DNHB peptide was evaluated from different 
NMR parameters, the root mean square deviation of ΔδHα (RMSΔδHα) values taken for the 
residues located on the strands
14,20,21,46,47
 and the ΔδGly in the turn of the hairpin18,20,21,31,48. The 
values determined for the DNHB peptides were compared to that obtained for Trpzip2, allowing us 
to rank DNHB peptides based on their conformational stability (Fig. 4 and Table S1). This analysis, 
a part from the validity of the two-state assumption, is limited by the absence of accurate reference 
values for the completely folded and random coil states which affects the precision and accuracy of 
the absolute quantification of β-sheet populations49 but it is still effective to compare and rank a 
homogenous set of peptides. The two methods, which monitor different structural elements, are in a 
good agreement. A comparison of fraction-folded values derived from both Gly7 H splitting and 
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the RMSH reveals that the cyclic peptides retain a folded -hairpin in the range of 31–96% 
with respect to Trpzip2 population.  
Peptides with the number of methyl units inverted (1.2 vs 2.1, 1.3 vs 3.1, or 2.3 vs 3.2) show a 
similar -hairpin content. Considering the azide component fixed and varying the alkynes on the N 
terminal strand, the β-hairpin content increases with the length of the side chain of the alkynes 
(DNHB1.1 < DNHB2.1 < DNHB3.1; DNHB1.2 < DNHB2.2 ≈ DNHB3.2; DNHB1.3 < DNHB2.3 
< DNHB3.3). At the same way, fixed the alkyne component, the β-hairpin content increases with 
the length of the side chain of the azide (DNHB1.1 ≈ DNHB1.2 < DNHB1.3; DNHB2.1< 
DNHB2.3 < DNHB2.2; DNHB3.1< DNHB3.2 ≈ DNHB3.3). It seems that a minimum side chain 
length is required (peptides DNHB 2.2, 2.3, 3.2, and 3.3) to obtain high conformational stable -
hairpin peptide. For example, peptide DNHB2.2 assumes a high β-hairpin content (96% and 85% 
based on ΔδGly and RMSH respectively) with respect to Trpzip2 peptide. We can speculate 
that the minimum length of the triazole bridge is needed to confer a sufficient conformational 
flexibility to the triazole linkage to be accommodated into an adequate -hairpin structure. 
 
Figure 4: Fraction folded of DNHB peptides as determined by RMSH and Gly H splitting 
values at 298 K, using limiting shift values derived from Trpzip2. 
 
Conformational analysis of DNHB2.2 peptide. To gain molecular details on the conformation 
assumed by DNHB peptides, we decided to characterize DNHB 2.2 peptide, which present the 
shortest bridge length between the peptide with highest -hairpin content. To this aim examination 
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of long-range NOEs between residues in antiparallel strands of the -hairpin was performed. 
Several strong interstrand HN–HN and H–HN interactions (Table S2) are readily detected, 
confirming the correct registry for the -hairpin. Additional week NOEs are seen between Hδ1, Hζ2 
and Hη2 of the Trp4 indole ring and the H proton of the 1,2,3-triazole moiety suggesting an 
aromatic–aromatic interaction (Fig. 5). Moreover, the 1,2,3-triazole H proton is upfield shifted 
(7.28 ppm) with respect to the value measured for the reference 1,2,3 triazole moiety (7.90 ppm in 
DMSO, 7.55 ppm in water
20
). At the last, the temperature coefficients reveal that the backbone 
amide protons of residues Thr3, Glu5, Lys8, Thr10 and Lys12 are likely involved in hydrogen 
bonding, suggesting that the inter-strand hydrogen-bonding pattern of the hairpin is the same as in 
Trpzip2 (Table S3).  
 
Figure 5: Aromatic region of the 2D NOESY spectrum of DNHB 2.2 cyclic peptide. Cross peaks 
between Hδ1, Hζ2 and Hη2 of Trp2 side chain and Hζ of 1,2,3 triazolyl moiety are highlighted. 
 
Successively, we verified if hairpin stabilization of DNHB2.2 is strand-dependent synthesizing the 
peptide DNHB 2.2rev, where the alkyne and azide components are reversed. A comparison of the 
H shifts for DNHB2.2 and DNHB2.2rev showed a similar profile for both peptides (Fig. 6A). 
Indeed, the folded population of DNHB2.2rev was calculated to be 94% folded with glycine 
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splitting and 78% with RMSH methods (Fig. 6B), indicating that no drastic change in hairpin 
folding occurs when the alkyne and azide components are exchanged.  
 
Figure 6: A) Hα chemical shift difference (ΔδHα) for Trpzip2 and for cyclic DNHB2.2, 
DNHB2.2rev and DNHB2.2W3 peptides. B) Fraction folded of DNHB2.2, DNHB2.2rev and 
DNHB2.2W3 peptides as determined by RMSH and Gly H splitting values at 298 K, using 
limiting shift values derived from Trpzip2. 
 
To investigate the influence of the aromatic interaction between the triazole moiety and the Trp4 
indole on the DNHB2.2 -hairpin conformation, we synthesized the DNHB2.2W3 peptide 
swapping Trp2 and Thr3 residues. In this way, the triazole ring and the Trp side chain fall on the 
two opposite side of the -hairpin. This peptide showed considerably less H downfield shifting 
(Fig. 6A). Moreover, very few cross-strand interactions were detected for DNHB2.2W3 by NOESY 
experiments which suggests a poorly folded system (Table S4). In DNHB2.2W3 no NOE cross-
peaks were detected between the 1,2,3-triazole and the indole ring, thus excluding aromatic 
interactions. The -hairpin folded population for DNHB 2.2W3 was estimated to be 29% and of 
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38% with respect to Trpzip2 based on RMSH and glycine splitting methods, respectively (Fig. 
6B). The strong -hairpin destabilization of DNHB2.2W3 and the NOEs between Trp4 indole 
protons ring and the H proton of the 1,2,3-triazole ring detected in DNHB 2.2, strongly support the 
role of aromatic interaction between the triazole ring and the tryptophan side chain on the 
conformational stability of the -hairpin peptide. It is well known that aromatic groups interact each 
other according specific geometric arrangements
33
; in particular aromatic amino acid residues 
interact using a T-shaped geometry with residues occupying a face or edge position. Upfield shifted 
resonance of a specific aromatic proton is indicative of an edge position
35,50
. In DNHB2.2 peptide, 
chemical shift of Trp aromatic protons are in random coil ranges indicating for this residue a face 
position; instead, triazole H proton is upfield shifted therefore suggesting an edge-like position. 
According with NMR analysis, the CD spectrum of cyclic DNHB2.2W3 in the far UV region shows 
a minimum around 200 nm with minor changes with respect to the linear peptide spectrum. This 
spectrum is different from the spectrum of DNHB2.2 peptide (Fig. 7A). Furthermore, we analyzed 
DNHB2.2 and DNHB2.2W3 peptides in the near UV region to analyze the CD spectra of aromatic 
chromophores (Fig. 7B). DNHB2.2W3 spectrum indicates the presence of an indole moiety 
completely exposed to the solvent as observed in L-Trp
51
 or in the dipeptide Gly-Trp
52
 in water 
which has been indicated as type 2 spectrum
53
. Instead, DNHB2.2 presents a type 3 spectrum with 
two negative minima at 281 and 288 nm as observed for cyclo(-His-Trp)
53
 or Trp-Trp
52
 in water 
suggesting that the indole is interacting with a close aromatic ring.  
14 
 
 
Figure 7: A) Far-UV circular dichroism  spectra of cyclic DNHB2.2W3 (black line) and DNHB2.2 
(red line) peptides in 10 mM phosphate buffer pH 6.6. B) Near-UV circular dichroism  spectra of 
cyclic DNHB2.2W3 (black line) and DNHB2.2 (red line) peptides in 10 mM phosphate buffer pH 
6.6. Spectra are reported in molar ellipticity ([]). 
 
The strong destabilization of the -hairpin structure observed in DNHB2.2W3 reveals that the 
triazole bridge (with x=y=2) in diagonal position is weakly stabilizing by itself. Similarly, the 
W2W9 peptide, a Trpzip2 analogue presenting only two tryptophan residues in a diagonal 
arrangement, mainly shows an unordered conformation
24
. In our previous study on the role of 
triazole bridge in NHB positions
20
 the values of the Gly splitting of the most stable peptide 
(NHB2.1) and its analogue with Trp flipped (NHB2.1W3) resulted comparable, therefore, 
suggesting that in the NHB peptide series the contribution of tryptophan side chain to the 
stabilization of the -hairpin is irrelevant. This result highlights that in order to establish an efficient 
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interaction between the triazole bridge and the Trp, it is not sufficient that the two aromatic rings 
are on the same side of the hairpin but an optimal reciprocal position should be found. Finally, 
comparing the -hairpin content of Trpzip2 and its analogue W2W4W9 with NHB2.1 and 
DNHB2.2 peptides (Fig. 8) we observed that the triazole bridge is less effective in replacing a 
cross-strand Trp pair (W2W4W9 vs NHB2.1) and more effective of a diagonal Trp-Trp interaction 
(W2W4W9 vs DNHB2.2). Furthermore, the formation of the triazole bridge covalently link the two 
-strands and it is expected to improve the metabolic stability of the peptide19,54. 
 
 
Figure 8. Comparison between -hairpin content of Trpzip and triazole bridged peptides. Top, 
schematic representation of studied -hairpin peptides. Red and blue circles indicate hydrogen 
bonded and non-hydrogen bonded position. The yellow segment represent the four residues forming 
the -turn. Bottom, correlation between Trp residues or triazole bridge position and peptide -
harpin content. 
a
Value taken from Celentano et al. 2012
20
 
 
Conclusion 
The triazole bridge-Trp interaction is an useful strategy to design peptides with high -hairpin 
content. In fact, triazole and indole rings favorable interact to stabilize a -hairpin conformation. 
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The conformational stabilization depends on the length of the triazole bridge and the reciprocal 
position between the two aromatic rings. Combining aromatic interactions and the inter-strand 
triazole bridge covalent tool peptides with high -hairpin content, similar to Trpzip2 peptide, have 
been obtained.  
 
Experimental 
Materials and methods 
The Rink Amide MBHA resin (0.51 mmol/g), Fmoc-amino acids and activators such as HOBt and 
HBTU were provided by Novabiochem (Merck group, UK). Solvents for peptide synthesis and 
purification, acetic anhydride, ascorbic acid and copper sulfate (II) were purchased from Sigma-
Aldrich (Italy). Alkyne and azide amino acids such as Fmoc-L-Dap (N3)-OH, Fmoc-L-Dab (N3)-
OH, Fmoc-L-Orn (N3)-OH, Fmoc-Pra-OH, Fmoc-Hpg-OH, Fmoc-Bpg-OH were from Iris Biotech 
GmbH (Germany) or Chiralix B. V. (The Netherlands). N,N-diisopropylethylamine (DIPEA) was 
purchased from Sigma-Aldrich (Italy), while the piperidine was provided by the company Biosolve 
(France). Products purification were carried out by liquid chromatography in reverse phase high 
pressure (RP-HPLC) using an Agilent 1200 equipped with a diode array detector. Peptides analysis 
were performed on the instrument LC-MS LCQ Deca XP MAX (Thermo Fisher Scientific, 
Massachusetts, U.S.) equipped with an ESI source and an ion trap mass analyzer coupled to a 
surveyor HPLC system. The reversed phase column were from Phenomenex (Torrance, USA). 
 
Peptide synthesis 
The synthesis of all peptides was performed in manual solid phase using Fmoc chemistry on Rink-
amide MBHA resin. After swelling of the resin in dimethylformamide (DMF) for about 30 minutes, 
Fmoc removal was effected by treating the resin with a basic solution constituted by 30% piperidine 
in DMF, twice for 5 minutes. The amino acids (2.5 equivalents) were coupled using solutions of 
HBTU/HOBt 0.45M (2.49 equivalents) in DMF, in the presence of DIPEA (5 equivalents). Double 
17 
 
couplings were performed 20 minutes at room temperature. The acetylation was carried out using a 
solution of acetic anhydride (2 M), DIPEA (0.55 M) and HOBt (0.06 M) dissolved in DMF for 5 
minutes. At the end of the synthesis, the resin was washed with DMF, DCM, diethyl ether and dried 
under vacuum. The peptides were detached from the resin and deprotected by a treatment with a 
solution of TFA/TIS/H2O (95:2.5:2.5, v/v/v) for three hours at room temperature. The crude 
peptides were precipitated in cold diethyl ether, collected after centrifugation, suspended in a 
solution of water/acetonitrile and lyophilized. The linear peptides were purified by preparative RP-
HPLC using a AXIA column (50 x 21.2 mm, 4 ) at a flow rate of 20 mL/min. The linear peptides 
were characterized by LC-MS using a C12 proteo column (50x2.0 mm, 4 m. Peptides analysis 
was performed on a RP-HPLC using a Proteo C12 column (4 µm, 90 Ǻ, 250 x 4.60 mm) and a 
linear gradient of H2O (0.1% TFA)/CH3CN (0.1% TFA) from 5% to 70% of CH3CN in 20 min. 
Analytical characterization of linear DNHB peptides: 
DNHB1.1: MS(m/z) [M+H]
+
calcd 1355.5, [M+2H]
2+
calcd 678.2, found 678.7; RP-HPLC tR=14.07 
min 
DNHB1.2: MS(m/z) [M+H]
+
calcd 1369.6, [M+2H]
2+
calcd 685.3, found 685.3; RP-HPLC tR=14.25 
min  
DNHB1.3: MS(m/z) [M+H]
+
calcd 1383.6, [M+2H]
2+
calcd 692.3, found 692.4; RP-HPLC tR=14.56 
min  
DNHB2.1: MS(m/z) [M+H]
+
calcd 1369.6, [M+2H]
2+
calcd 685.2, found 685.4; RP-HPLC tR=14.22 
min  
DNHB2.2: MS(m/z) [M+H]
+
calcd 1383.5, [M+2H]
2+
calcd 692.3, found 692.3; RP-HPLC tR=14.55 
min  
DNHB2.3: MS(m/z) [M+H]
+
calcd 1397.6, [M+2H]
2+
calcd 699.3, found 699.4; RP-HPLC tR=14.85 
min  
DNHB3.1: MS(m/z) [M+H]
+
calcd 1383.5, [M+2H]
2+
calcd 692.2, found 692.6; RP-HPLC tR=14.37 
min  
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DNHB3.2: MS(m/z) [M+H]
+
calcd 1397.6, [M+2H]
2+
calcd 699.3, found 699.5; RP-HPLC tR=14.55 
min  
DNHB3.3: MS(m/z) [M+H]
+
calcd 1411.6, [M+2H]
2+
calcd 706.3, found 706.2; RP-HPLC tR=14.94 
min  
DNHB2.2rev: MS(m/z) [M+H]
+
 calcd 1383.5, [M+2H]
2+
calcd 692.3, found 692.6; RP-HPLC 
tR=14.21 min 
DNHB2.2W3: MS(m/z) [M+H]
+
calcd 1383.5, [M+2H]
2+
calcd 692.3, found 692.6; RP-HPLC 
tR=14.17 min 
 
Cu-catalyzed alkyne-azide cycloaddition 
The purified linear peptides (0.5mM) dissolved in H2O/CH3OH (2:1 v/v) were cyclized using 
CuSO4  (14 eq) and ascorbic acid (13 eq), the mixture  was degassed with a gentle flow of N2 for 5 
min and then was stirred at room temperature for 1 h. Crude peptides were purified by RP-HPLC 
on a C12 proteo column (250x10.00 mm, 10 μm; flow = 5mL/min), the fractions were pooled and 
lyophilized. Clicked peptides purity were verified by analytical RP-HPLC using the specified 
gradient of CH3CN (0.1% TFA) in H2O (0.1% TFA) from 5% to 70% in 20 min. The purified cyclic 
peptides were characterized by LC-MS using a C12 proteo column (50x4.6mm, 4μm).  
DNHB 1.1: MS (m/z) [M+H]
2+
 calcd 1355.5, [M+2H]
2+
 calcd 678.2, found 678.4; RP-HPLC 
tR=12.44 min  
DNHB 1.2: MS(m/z) [M+H]
+
 calcd 1369.6, [M+2H]
2+
 calcd 685.3, found 685.3; RP-HPLC 
tR=12.55 min  
DNHB 1.3: MS(m/z) [M+H]
+
 calcd 1383.6, [M+2H]
2+
 calcd 692.3, found 692.4; RP-HPLC 
tR=12.79 min  
DNHB 2.1: MS(m/z) [M+H]
+
 calcd 1369.6, [M+2H]
2+
 calcd 685.2, found 685.4; RP-HPLC 
tR=12.62 min  
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DNHB 2.2: MS(m/z) [M+H]
+
 calcd 1383.5, [M+2H]
2+
 calcd 692.3, found 692.4; RP-HPLC  
tR=12.66 min  
DNHB 2.3: MS (m/z) [M+H]
+
 calcd 1397.6, [M+2H]
2+
 calcd 699.3, found 699.4; RP-HPLC 
tR=12.92 min 
DNHB 3.1: MS(m/z) [M+H]
+
 calcd 1383.5, [M+2H]
2+
calcd 692.2, found 692.5; RP-HPLC  
tR=12.85 min  
DNHB 3.2: MS(m/z) [M+H]
+
 calcd 1397.6, [M+2H]
2+
calcd 699.3, found 699.3; RP-HPLC  
tR=12.84 min  
DNHB 3.3: MS(m/z) [M+H]
+
 calcd 1411.6, [M+2H]
2+
calcd 706.3, found 706.4; RP-HPLC 
tR=13.17 min 
DNHB 2.2rev: MS(m/z) [M+H]
+
 calcd 1383.5, [M+2H]
2+
calcd 692.3, found 692.5; RP-HPLC 
tR=12.8 min 
DNHB 2.2W3: MS(m/z) [M+H]
+
 calcd 1383.5, [M+2H]
2+
calcd 692.3, found 692.5; RP-HPLC 
tR=13.32 min 
 
Reduction reaction 
Reduction reactions were carried out using the reducing agent tris (2-carboxyethyl) phosphine 
(TCEP) solubilized in a Tris HCl buffer (50 mM), pH 7.5. The reducing solution was added to the 
cyclized purified peptides and to pure linear peptide DNHB 3.3, used as a reference of the reduction 
occurred. The reaction was left under stirring overnight. Analysis of the crudes was performed by 
ESI mass spectrometry using a Jupiter C18 column (5 , 300 Ǻ, 250 x 2.0 mm) and a linear 
gradient of CH3CN (0.05% TFA) in H2O (0.05% TFA) from 5% to 70% in 20 minutes. 
DNHB 1.1: MS (m/z) [M+H]
2+
 calcd 1355.5, [M+2H]
2+
 calcd 678.2, found 678.4;  
DNHB 1.2: MS (m/z) [M+H]
+
 calcd 1369.6, [M+2H]
2+
 calcd 685.3, found 685.5;  
DNHB 1.3: MS (m/z) [M+H]
+
 calcd 1383.6, [M+2H]
2+
 calcd 692.3, found 692.5 
DNHB 2.1: MS (m/z) [M+H]
+
 calcd 1369.6, [M+2H]
2+
 calcd 685.2, found 685.5;  
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DNHB 2.2: MS (m/z) [M+H]
+
 calcd 1383.5, [M+2H]
2+
 calcd 692.3, found 692.5 
DNHB 2.3: MS (m/z) [M+H]
+
 calcd 1397.6, [M+2H]
2+
 calcd 699.3, found 699.4 
DNHB 3.1: MS (m/z) [M+H]
+
 calcd 1383.5, [M+2H]
2+
 calcd 692.2, found 692.5;  
DNHB 3.2: MS (m/z) [M+H]
+
 calcd 1397.6, [M+2H]
2+
 calcd 699.3, found 699.5;  
DNHB 3.3: MS (m/z) [M+H]
+
 calcd 1411.6, [M+2H]
2+ 
calcd 706.5, found 706.3;  
DNHB 3.3 lin red: MS (m/z) [M+H]
+
 calcd 1385.6, [M+2H]
2+
 calcd 693.3, found 693.5. 
 
CD spectroscopy 
The far-UV circular dichroism spectra were recorded using the J-810 spectropolarimeter (Jasco, 
Easton, US) equipped with a thermoregulation system Peltier PTC-423S/15, using quartz cells of 
0.1 cm (Hellma , Milan, Italy). The peptides were solubilized in phosphate buffer (10 mM) pH 6.6 
at a concentration of 50 M. Circular dichroism spectra were recorded at 20 °C using a 260–190 
nm measurement range, 10 nm/min scanning speed, 2 nm bandwidth, 4 s response time, 0.2 nm 
data pitch. Near-UV CD spectra were collected on a Jasco 720 (Easton, MD, US) 
spectropolarimeter, in the wavelength range 260-340 nm, using a 1 cm path-length quartz cuvette 
(Hellma, Milan, Italy) filled with 1.9 mL of peptide solutions. Spectra were collected at 20 °C, 
setting the following parameters: scanning speed 10 nm/min, bandwidth 2.0 nm, data pitch 0.2 nm, 
response 4 s, standard sensitivity and three spectra accumulations. Aliquots of the lyophilized 
peptides were dissolved in 10 mM potassium phosphate buffer pH 6.6 and centrifuged at 13200 
rpm for 3 minutes, at room temperature. Supernatants were recovered, diluted to 1.9 mL with 
buffer and analyzed by CD.  
Peptide concentrations were determined by evaluating the absorbance at 280 nm using a molar 
extinction coefficient of 5500 M
−1
 cm
−1
. CD spectra are displayed in molar ellipticity. The 
processing of the spectra was obtained by using the Spectra Manager software (Jasco corporation, 
ver. 1.53.01). Spectra have been smoothed for clarity. 
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NMR spectroscopy 
NMR samples were prepared dissolving the lyophilized peptides in H2O/
2
H2O (9:1 v/ v) at final 
concentrations ranging from 0.5 to 1.0 mM. The sodium 2,2-dimethyl-2-silapentane-5-sufonate 
(DSS) has been used as an internal reference. All NMR spectra were acquired on a Varian INOVA 
400 Hz spectrometer. The suppression of the water signal was obtained through sequences Double 
Pulsed Field Gradient Spin Echo
55
. All spectra were processed with a software Sparky (Goddard, 
TD & Kneller, DG. SPARKY3, 2001) and analyzed with Neasy supported by a computer-aided 
resonance assignment (CARA) software
56
. The fraction folded was determined using the splitting 
Ha of glycine 7 in the turn by the equation: (ΔδGlyobs)/(ΔδGly100) where ΔδGlyobs is the difference 
between the value of proton chemical shifts of glycine in the peptide cyclized and ΔδGly100 is the 
value of the proton chemical shifts of Glycine in Trpzip2. Moreover, simultaneously, an RMSD 
value taken over all residues (RMSΔδHα) as a measure of β-strand stability at a given temperature 
was calculated. The ratio  RMSΔδHα/ RMSΔδHαlimit where the RMSΔδHαlimit is the Trpzip2 value,  
was used to calculate the -hairpin fraction folded.  
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